Establishment and characterization of primary lung cancer cell lines from Chinese population
- PMID: 21372829
- PMCID: PMC4002770
- DOI: 10.1038/aps.2010.214
Establishment and characterization of primary lung cancer cell lines from Chinese population
Abstract
Aim: To establish and characterize primary lung cancer cell lines from Chinese population.
Methods: Lung cancer specimens or pleural effusions were collected from Chinese lung cancer patients and cultured in vitro with ACL4 medium (for non-small cell lung carcinomas (NSCLC)) or HITES medium (for small cell lung carcinomas (SCLC)) supplemented with 5% FBS. All cell lines were maintained in culture for more than 25 passages. Most of these cell lines were further analyzed for oncogenic mutations, karyotype, cell growth kinetics, and tumorigenicity in nude mice.
Results: Eight primary cell lines from Chinese lung cancer patients were established and characterized, including seven NSCLC cell lines and one SCLC cell line. Five NSCLC cell lines were found to harbor epidermal growth factor receptor (EGFR) kinase domain mutations.
Conclusion: These well-characterized primary lung cancer cell lines from Chinese population provide a unique platform for future studies of the ethnic differences in lung cancer biology and drug response.
Figures
Similar articles
-
EGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features.Int J Mol Sci. 2013 Dec 17;14(12):24549-59. doi: 10.3390/ijms141224549. Int J Mol Sci. 2013. PMID: 24351833 Free PMC article.
-
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.Nat Commun. 2015 Mar 11;6:6377. doi: 10.1038/ncomms7377. Nat Commun. 2015. PMID: 25758528 Free PMC article.
-
Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer.Med Oncol. 2014 Mar;31(3):803. doi: 10.1007/s12032-013-0803-5. Epub 2014 Jan 23. Med Oncol. 2014. PMID: 24452282
-
[Morphological and molecular pathology of lung cancer].Pathologe. 2010 Oct;31 Suppl 2:204-10. doi: 10.1007/s00292-010-1371-5. Pathologe. 2010. PMID: 20852864 Review. German.
-
A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.Adv Exp Med Biol. 2014;799:85-117. doi: 10.1007/978-1-4614-8778-4_5. Adv Exp Med Biol. 2014. PMID: 24292963 Review.
Cited by
-
SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression.Front Oncol. 2022 May 30;12:862250. doi: 10.3389/fonc.2022.862250. eCollection 2022. Front Oncol. 2022. PMID: 35707369 Free PMC article.
-
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma.Sci Rep. 2019 Dec 27;9(1):19909. doi: 10.1038/s41598-019-56356-4. Sci Rep. 2019. PMID: 31882684 Free PMC article.
-
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.Oncologist. 2016 Feb;21(2):156-64. doi: 10.1634/theoncologist.2015-0288. Epub 2016 Jan 14. Oncologist. 2016. PMID: 26768482 Free PMC article.
-
Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.Elife. 2015 Feb 16;4:e06132. doi: 10.7554/eLife.06132. Elife. 2015. PMID: 25686219 Free PMC article.
-
The application of patient-derived organoid in the research of lung cancer.Cell Oncol (Dordr). 2023 Jun;46(3):503-519. doi: 10.1007/s13402-023-00771-3. Epub 2023 Jan 25. Cell Oncol (Dordr). 2023. PMID: 36696006 Free PMC article. Review.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49. - PubMed
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. - PubMed
-
- Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002;2:315–9. - PubMed
-
- Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17:62–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous